“Going forward, PolyNovo and Beta Cell are in collaboration discussions to accelerate research anddevelopment pathways to ensure PolyNovo’s technology can play a major role in the cell therapymarket space which is estimated to be USD $34 Billion by 2034. Professors Coates andGreenwood are subject matter experts and will guide PolyNovo’s involvement.”
Ann: BTM delivers positive First in Man results in Cell Therapies, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
-0.030(2.55%) |
Mkt cap ! $791.0M | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.18 | $1.15 | $2.259M | 1.955M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 23457 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 55555 | 1 |
View Market Depth
| Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
| PNV (ASX) Chart |